Location History:
- Vancouver, CA (2021)
- Surrey, CA (2012 - 2024)
Company Filing History:
Years Active: 2012-2024
Title: The Innovative Contributions of Stephen P Reid
Introduction
Stephen P Reid is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of therapeutic agent delivery, holding a total of 6 patents. His work focuses on developing novel lipid formulations that enhance the delivery of therapeutic agents, particularly in cancer treatment.
Latest Patents
One of Reid's latest patents involves lipid formulations designed for the delivery of therapeutic agents. This invention provides novel, serum-stable lipid particles that comprise one or more active agents or therapeutic agents. The patent details methods for creating these lipid particles and outlines techniques for their delivery and administration. Specifically, it introduces serum-stable nucleic acid-lipid particles (SNALP) that include nucleic acids, such as interfering RNA molecules. The invention emphasizes the creation of tumor-directed lipid particles that preferentially target solid tumors, allowing for more effective delivery of therapeutic payloads to cancerous cells while minimizing impact on non-cancerous cells.
Career Highlights
Throughout his career, Stephen P Reid has worked with prominent companies in the biopharmaceutical sector. He has been associated with Arbutus Biopharma Corporation and Protiva Biotherapeutics, Inc., where he has contributed to advancing therapeutic technologies. His expertise in lipid formulations has positioned him as a key figure in the development of innovative cancer treatments.
Collaborations
Reid has collaborated with notable professionals in his field, including James Heyes and Adam Judge. These partnerships have further enhanced his research and development efforts, leading to impactful innovations in therapeutic delivery systems.
Conclusion
Stephen P Reid's contributions to the field of therapeutic agent delivery through his innovative lipid formulations have made a significant impact on cancer treatment. His work continues to inspire advancements in biopharmaceutical technologies.